Newsletters
DTN 013: The State of AI 2023
Plus: A guy makes ChatGPT the CEO of his company, China inserts tardigrade DNA into human stem cells, and more
Newsletters
Plus: A guy makes ChatGPT the CEO of his company, China inserts tardigrade DNA into human stem cells, and more
Newsletters
Plus: A leaky nuclear reactor, a chatbot suicide, a government crypto conspiracy, artificial cells, and more.
Newsletters
Plus: A landmine hunting drone, Japan's geothermal opportunity, successful launch of the world's first 3D printed rocket, DeSantis and Cruz go after CBDCs, and more.
Newsletters
Plus: Neuromarketing, a samurai sword NFT, regenerating bone from antlers, betrothed in a VR Taco Bell, AI searches for ET, and more.
Newsletters
Plus: Playboy in the metaverse, the vertical farming bubble is popping, a vertical solar power tower, $100M for a bat biology startup, and more.
Newsletters
Plus: Lab-grown meat is vegan, the birth of an AI porn industry, supercomputer warns of a second dust bowl, stem cell transplant cures 5th person of HIV, and more.
Newsletters
Plus: Japan falls back in love with nuclear energy, DIY genetic engineering, an intercontinental network of robotic telescopes, Blue Origin made solar cells out of fake moon dirt, and more.
Newsletters
Plus: Battery investments are booming, lab grown meat won't give you cancer, DARPA's orbital laser internet, the sex life of death cap mushrooms, and more.
Newsletters
Plus: South Park creators land $20M for deep fake company, a company is bringing back the Dodo, water ATMs, how AI and EVs can save the bees, and more.
Newsletters
Plus: an AI for smells, a nuclear Mars rocket, a first nuclear fuel recycling facility, Ferrari simulating engine sounds for EVs, and more.
Newsletters
Plus: an AI scientist that engineers living cells, blockchains in space, World Economic Fund and Linux enter metaverse, scientists reverse aging in mice, and more.
Newsletters
Plus: Microsoft's voice deepfakes, GPT fools scientists, crypto on the space station, the end of animal testing for drug trials, and more.